Previous 10 | Next 10 |
BASKING RIDGE, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disea...
Approval received from the Japan Patent Office to use HONEDRA® as brand name for CLBS12 in Critical Limb Ischemia and Buerger’s Disease Intellectual property provides additional coverage of CD34+ cell technology in Japan BASKING RIDGE, N.J., Sept. 09, 2020 (GLOBE NEWSWI...
BASKING RIDGE, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disea...
BASKING RIDGE, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disea...
Caladrius Biosciences Inc. (NASDAQ: CLBS) is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. The company is developing a first-in-class cell therapy product that is based on the notion that the human body c...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
BASKING RIDGE, NJ / ACCESSWIRE / August 27, 2020 / Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced that manageme...
4 Biotech Penny Stocks To Watch Right Now One of the top sectors for penny stocks and blue-chips alike has been biotechnology and healthcare. Obviously, the global pandemic and search for a coronavirus vaccine upped the attention on this sector in 2020. Aside from that, however, we’...
Taiwan Liposome (NASDAQ: TLC ) +103% on planned trial of inhaled malaria drug for COVID-19. More news on: Taiwan Liposome Company, Ltd., Mesoblast Limited, Midatech Pharma plc, Stocks on the move, , Read more ...
Caladrius Biosciences, Inc. (CLBS) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants John Menditto – Vice President, Investor Relations and Corporate Communications David Mazzo – President and Chief Executive Officer Conference Call P...
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...